07/03/2025 | Press release | Archived content
For many patients, the biggest limitation in cardiac care is the gap between what traditional episodic testing can capture and the intermittent nature of heart issues. Nearly 50% of cardiac arrhythmias go undiagnosed through conventional testing, and approximately 30% of strokes are attributed to previously undetected heart rhythm disorders.
But what if your heart test didn't end when you left the doctor's office? Innovations like the mini EKG and 7-day heart monitor patch are closing the gap by extending cardiac diagnostics into the outpatient setting and transforming how cardiovascular conditions are detected, monitored, and managed.
Biotricity's Bioheart is a 3-lead strap-based cardiac monitor that can be purchased by consumers or used by physicians to monitor individuals with chronic cardiac disease through remote patient monitoring (RPM) and chronic care management (CCM) programs. Compact devices, such as Bioheart, offer cardiac assessment capabilities previously only available in clinical settings.
A mini EKG device like Bioheart provides:
Unlike other mini EKG devices, Bioheart provides clinical-grade heart monitoring 24/7 during use. Other mini EKG devices are user-initiated, capturing heart data only when the user actively takes a recording, typically when they are symptomatic. Bioheart's advanced technology empowers individuals to take an active role in their cardiac health.
The 7-day heart monitor patch technology takes cardiac monitoring to another level by providing continuous assessment over an extended period.
When a physician prescribes a 7-day heart monitor patch, such as Biotricity's Biocore Pro (a 3-lead connected cardiac patch monitor prescribed by physicians to individuals 18+), patients experience:
Biocore Pro stands out among other 7-day heart monitor patch devices. Biocore Pro is a wireless, lightweight patch that adheres comfortably to the chest, continuously recording heart activity through its sophisticated 3-lead configuration. Unlike bulky Holter monitors used in most heart test diagnostics that are limited to 1- or 2-leads, the Biocore Pro heart monitor patch is discreet and doesn't interfere with daily activities. Biocore Pro is connected, and data is transmitted from Biocore Pro to the Biocare platform for healthcare provider review (source).
Many cardiac issues occur sporadically. A patient experiencing occasional palpitations might show normal results during a standard 24-48 hour Holter heart test. Extended monitoring increases detection rates, diagnostic yield more than doubles from 24% in 48-hour monitoring to over 50% using 7-day heart monitor patch technology.
Traditional heart tests fall short because they only capture a brief snapshot of heart activity, often missing irregular symptoms patients experience between appointments. Both the mini EKG and 7-day heart monitor patch solve this problem by capturing data continuously, giving healthcare providers the full picture (source).
Modern monitoring devices are compact and wireless to fit any lifestyle and any activity, providing more relevant cardiac data and better compliance (source).
People with risk factors for heart disease can use a mini EKG to establish personal cardiac baselines and monitor for changes over time (source).
Patients with diagnosed conditions benefit from the 7-day heart monitor patch through assessment of treatment effectiveness and early detection of worsening conditions (source).
When symptoms are difficult to diagnose, extended monitoring can be the difference between answers and uncertainty, reducing the need to repeat a heart test (source).
The mini EKG and 7-day heart monitor patch technologies represent significant advancements in how we approach heart test diagnostics and preventative care as a whole. By extending the observation window and providing more comprehensive data, these innovations are transforming cardiovascular care and creating a future where cardiac health can be monitored more effectively, leading to better outcomes and improved quality of life.